Feb 19, 2013, 10.59 AM | Source: CNBC-TV18
Short Dr Reddys Laboratories, says Sudarshan Sukhani of s2analytics.com.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, " Dr Reddys Laboratories is a sell and it is a surprise. It started falling and we thought that this is a correction, but it was not. It is now breaking all kinds of support levels and making a distribution pattern that promises that what we are looking at is an intermediate downtrend, not just a short-term correction.”
He further added, “I think perhaps it is company specific, but whatever the reason Dr Reddys is now a short selling idea. Even in a market that could go up probably this one is likely to underperform.”
The share touched its 52-week high Rs 1,968.60 and 52-week low Rs 1,555.00 on 25 January, 2013 and 19 June, 2012, respectively. Currently, it is trading 8.54% below its 52-week high and 15.79% above its 52-week low. Market capitalisation stands at Rs 30,579.91 crore.
Disclosure: I have no holdings or interest in the stock discussed.
Dr Reddys mulls share buyback, board to meet next week
A meeting of the Board of Directors of the company
Board to consider buyback of equity shares on Feb 17: Dr Reddy's
Saumen Chakraborty, President and CFO, Dr Reddy's
Dr Reddy's Laboratories shares gain 3% on buyback buzz
The company's consolidated net profit was up margi
Dr Reddy's Laboratories to consider buyback of equity shares
Dr Reddys Laboratories Ltd has informed BSE that a
Buy Dr Reddys Labs; target of Rs 3083: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Dr Reddys Labs h
Buy Dr Reddys Labs; target of Rs 3610: KRChoksey
KRChoksey is bullish on Dr Reddys Labs has recomme
Indian ADRs: HDFC Bank, Tata Motors gain; Dr Reddy's slips
In the banking space, ICICI Bank fell 0.08 percent
Facebook India Head Kirthiga Reddy to relocate to US